Advertisement

GI Dynamics Inc., a Lexington medical device firm, has announced results of three studies of its EndoBarrier Gastrointestinal Liner in treating type 2 diabetes and obesity.

The EndoBarrier, inserted in the GI tract endoscopically, was found to improve glycemic control and weight loss, according to a news release from the company. The study involved 17 obese patients using the implanted EndoBarrier for 24 weeks.

SOURCE

Advertisement
Advertisement